Quantitative brain regional relaxometry metrics for early diagnosis of Parkinson's disease

Synthetic MRI-derived regional relaxometry reveals stage-related brain alterations in PD. T1-based gray-matter metrics show relatively robust performance under internal validation and may serve as candidate imaging markers associated with early disease-related changes and progression in Parkinson's disease. However, all classification results should be regarded as exploratory and warrant further validation in larger, independent cohorts.